博拓生物 (688767.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(博拓生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 121,621,909.77131,530,384.09135,626,648.51129,871,567.63100,162,558.53108,390,472.22103,685,805.87
 营业收入(元) 121,621,909.77131,530,384.09135,626,648.51129,871,567.63100,162,558.53108,390,472.22103,685,805.87
二、营业总成本(元) 105,531,898.3690,726,658.3291,142,982.4682,499,588.5074,560,808.5249,819,037.2992,088,830.56
 营业成本(元) 63,795,414.2462,360,295.0674,822,867.8038,210,401.2256,260,018.6665,922,271.8659,197,553.49
 研发费用(元) 13,584,882.9915,714,373.6914,645,403.8436,729,595.0015,156,563.7118,708,822.399,880,272.83
 营业税金及附加(元) 1,440,670.573,457,854.081,348,082.071,340,677.93195,344.661,772,408.022,146,906.72
 销售费用(元) 6,828,551.346,846,416.144,488,401.7110,806,971.006,012,450.295,453,071.415,610,266.22
 管理费用(元) 15,743,359.1519,032,325.3113,005,826.8914,446,479.2413,553,257.2212,432,789.8010,893,383.47
 财务费用(元) 4,139,020.07-16,684,605.96-17,167,599.85-19,034,535.89-16,616,826.02-54,470,326.194,360,447.83
  其中:利息费用(元) 4,377.04------
  其中:利息收入(元) 8,715,630.56------
 资产减值损失(元) -3,800,823.83-5,162,021.03-405,996.24-47,472,219.36-123,521.20-7,017,617.01-661,285.63
 信用减值损失(元) -875,710.85-737,029.56236,675.18-618,931.71-731,955.14-1,601,070.77-609,805.11
三、其他经营收益
 加:公允价值变动收益(元) ------1,788,018.431,723,502.30
 加:投资收益(元) 3,945,456.251,293,506.78-271,329.44-364,865.11389,260.262,990,618.57364,931.52
  其中:对联营企业和合营企业的投资收益(元) -174,002.72-176,875.14-286,534.91----
 资产处置收益(元) ---49,756.60105,928.25852.81--
 其他收益(元) 2,934,420.58345,347.73541,941.9326,643,460.22661,557.49288,064.911,542,649.41
四、营业利润(元) 18,293,353.5636,543,529.6944,535,200.8825,729,867.5525,797,944.2351,338,893.6313,956,967.80
 加:营业外收入(元) -926.24107,725.462,691.48-12,100,888.457,938,053.104,761,532.309,450.00
 减:营业外支出(元) 2,734.923,361.201,254.411,213,867.86340,778.27-295,160.45295,237.01
五、利润总额(元) 18,289,692.4036,647,893.9544,536,637.9512,415,111.2433,395,219.0656,395,586.3813,671,180.79
 减:所得税费用(元) 2,086,619.835,746,109.795,002,305.82-2,823,723.834,297,258.896,934,823.302,168,938.40
六、净利润(元) 16,203,072.5730,901,784.1639,534,332.1315,238,835.0729,097,960.1749,460,763.0811,502,242.39
(一)按经营持续性分类
  持续经营净利润(元) 16,203,072.5730,901,784.1639,534,332.1315,238,835.0729,097,960.1749,460,763.0811,502,242.39
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 17,036,624.1832,543,748.6039,631,348.5915,077,911.3029,925,011.2749,703,499.6311,899,389.65
  少数股东损益(元) -833,551.61-1,641,964.44-97,016.46160,923.77-827,051.10-242,736.55-397,147.26
 扣除非经常性损益后的净利润(元) 11,043,983.7230,665,020.8439,439,732.293,569,539.7422,573,407.6944,227,102.219,055,122.92
七、每股收益
 一、基本每股收益(元) 0.160.310.380.140.280.470.11
 二、稀释每股收益(元) 0.160.310.380.140.280.470.11
八、其他综合收益(元) -2,724,656.11677,177.83256,146.39-2,585,971.45-127,824.12436,487.87707,863.98
 归属于母公司股东的其他综合收益(元) -2,768,195.71672,446.99250,178.88-2,479,507.24-115,041.72392,839.08637,077.59
 归属于少数股东的其他综合收益(元) 43,539.604,730.845,967.51-106,464.21-12,782.4043,648.7970,786.39
九、综合收益总额(元) 13,478,416.4631,578,961.9939,790,478.5212,652,863.6228,970,136.0549,897,250.9512,210,106.37
 归属于母公司所有者的综合收益总额(元) 14,268,428.4733,216,195.5939,881,527.4712,598,404.0629,809,969.5550,096,338.7112,536,467.24
 归属于少数股东的综合收益总额(元) -790,012.01-1,637,233.60-91,048.9554,459.57-839,833.51-199,087.76-326,360.87
公告日期 2024-10-302024-08-302024-04-272024-04-272023-10-282023-08-302023-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院